Literature DB >> 32315758

The immediate mental health impacts of the COVID-19 pandemic among people with or without quarantine managements.

Shen Zhu1, Yue Wu1, Chun-Yan Zhu2, Wan-Chu Hong1, Zhi-Xi Yu1, Zhi-Ke Chen1, Zhen-Lei Chen1, De-Guo Jiang3, Yong-Guang Wang4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32315758      PMCID: PMC7165285          DOI: 10.1016/j.bbi.2020.04.045

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


× No keyword cloud information.
In China, the Corona Virus Disease 2019 (COVID-19) was first identified in the city of Wuhan and had spread rapidly across the whole country. To control COVID-19 pandemic, Chinese government had implemented a range of strict quarantine managements for different population. Patients with COVID-19 were isolated in hospital, whereas close-contacts and the frontline medical personnel were quarantined in hotel. Notably, all the residents were under home-quarantine during the peak of pandemic, except those who guaranteed the basic functions of a city. These critical control measures substantially mitigated the spread of COVID-19, with conceivable impacts on people’s daily life. We, here, use a mental health survey data to test that whether the mental health problems were related to quarantine or not. Data was gathered with a mobile app called “Sojump” (www.sojump.com) after obtaining informed consent (from Feb. 12, 2020 to Mar. 17, 2020). In total, 1443 participants with quarantine (i.e., 206 close-contacts and 320 frontline medical personnel under hotel-quarantine, and 917 public residents under home-quarantine) and 836 participants without quarantine were recruited (i.e., 538 non-frontline medical personnel and 298 community support workers). The survey was completed after more than 10 days in quarantine and the same month for the participants with and without quarantine, respectively. The current work was approved by the ethics committees of the Fifth Hospital of Ruian. The 20-item Self-Report Questionnaire (SRQ-20), 7-item Generalized Anxiety Disorder Scale (GAD-7), and 9-item Patient Health Questionnaire (PHQ-9), were administered to screen the general psychological symptoms (i.e., ≥7 in SRQ-20), anxiety (i.e., ≥5 in GAD-7) and depression (i.e., ≥5 in PHQ-9), respectively. The Cronbach’s alpha for SRQ-20, GAD-7, and PHQ-9 was 0.884, 0.935, and 0.913, separately. In addition, participants were required to rate their subjective perception of impacts on daily life due to COVID-19 pandemic (0 – not at all; 1 – affected a little; 2 – affected a lot; and 3 – extremely affected). No significant difference was found for the screening-positive rate of SRQ-20, GAD-7, and PHQ-9 between participants with and without quarantine (all p ≥ 0.303). Logistic regression revealed that the screening-positive rate of SRQ-20 (OR = 3.593, 95% CI = 3.020–4.276), GAD-7 (OR = 4.686, 95% CI = 3.937–5.579), and PHQ-9 (OR = 4.313, 95% CI = 3.640–5.111) were significantly associated with impacts on daily life (all p < 0.001), but not the variable of with/without quarantine (all p ≥ 0.303) or different-group (all p ≥ 0.614). The characteristics for each group and the statistical results were shown in Table 1 .
Table 1

The characteristics for each group and the statistical results.

Participants with quarantine
Participants without quarantine
Statistics
OverallCCFMPPROverallCSWnFMPWith vs. without quarantineAmong groupsMultiple comparisons
(Hotel-quarantine)
(Home-quarantine)
(n = 1443)(n = 206)(n = 320)(n = 917)(n = 836)(n = 298)(n = 538)
Genderχ2 = 0.059, p = 0.808χ2 = 114.821, p < 0.001nFMP > FMP/PR/CC > CSW, all p < 0.05
 The ratio of female859 (59.5%)105 (51.0%)204 (63.7%)550 (60.0%)502 (60.0%)109 (36.6%)393 (73.0%)



Age-bracketχ2 = 1.268, p = 0.260χ2 = 0.340, p = 0.560/
≤30 years  old330 (22.9%)49 (23.8%)85 (26.6%)196 (21.4%)181 (21.7%)30 (10.1%)151 (28.1%)
 31–40 years old629 (43.6%)85 (41.3%)150 (46.9%)394 (43.0%)346 (41.4%)122 (40.9%)224 (41.6%)
 41–50 years old354 (24.5%)61 (29.6%)83 (25.9%)210 (22.9%)236(28.2%)97 (32.6%)139 (25.8%)
 ≥51 years old130 (9.0%)11 (5.3%)2 (0.6%)117 (12.8%)73(8.7%)49 (16.4%)24 (4.5%)



Educational levelwithout > with χ2 = 223.825, p < 0.001χ2 = 319.992, p < 0.001FMP/nFMP > CSW > PR > CC, all p < 0.05
 Primary school level68 (4.7%)40 (19.4%)0 (0%)28 (3.1%)5 (0.6%)5 (1.7%)0 (0%)
 Second school level487 (33.8%)135 (65.5%)7 (2.2%)345 (37.6%)65 (7.8%)56 (18.8%)9 (1.7%)
 High school level888 (61.5%)31 (15.1%)313 (97.8%)544 (59.3%)766 (91.6%)237 (79.5%)529 (98.3%)



Impacts on daily lifeχ2 = 1.402, p = 0.236χ2 = 2.208, p = 0.137/
 Not at all379 (26.3%)63 (30.6%)94 (29.4%)222 (24.2%)235 (28.1%)80 (26.8%)155 (28.8%)
 Affected a little818 (56.7%)94 (45.6%)178 (55.6%)546 (59.5%)471 (56.4%)149 (50.0%)322 (59.9%)
 Affected a lot203 (14.0%)44 (21.4%)42 (13.1%)117 (12.8%)108 (12.9%)55 (18.5%)53 (9.9%)
 Extremely affected43 (3.0%)5 (2.4%)6 (1.9%)32 (3.5%)22 (2.6%)14 (4.7%)8 (1.5%)



Rate of screening-positive
 SRQ-20216 (15.0%)14 (6.8%)41 (12.8%)161 (17.6%)112 (13.4%)58 (19.5%)54 (10.0%)χ2 = 1.061, p = 0.303χ2 = 32.252, p < 0.001PR/CSW > CC/nFMP, all p < 0.05
 GAD-7320 (22.2%)38 (18.4%)63 (19.7%)219 (23.9%)174 (20.8%)82 (27.5%)92 (17.1%)χ2 = 0.579, p = 0.447χ2 = 17.262, p = 0.002all p greater than 0.05
 PHQ-9319 (22.1%)26 (12.6%)68 (21.3%)225 (24.5%)174 (20.8%)77 (25.8%)97 (18.0%)χ2 = 0.522, p = 0.470χ2 = 21.686, p < 0.001PR/CSW > CC, PR > nFMP, all p < 0.05

Notes for Table 1: CC, group of close-contacts; FMP, group of frontline medical personnel; PR, group of public residents; CSW, group of community support workers; nFMP, group of non-frontline medical personnel; Pearson chi-square test for ratio; linear-by-linear association test for distribution; Bonferroni correction for multiple comparisons.

The characteristics for each group and the statistical results. Notes for Table 1: CC, group of close-contacts; FMP, group of frontline medical personnel; PR, group of public residents; CSW, group of community support workers; nFMP, group of non-frontline medical personnel; Pearson chi-square test for ratio; linear-by-linear association test for distribution; Bonferroni correction for multiple comparisons. Consistent with other reports (e.g., Li et al., 2020, Wang et al., 2020, Zhang et al., 2020), our results show a relative high prevalence of mental health problems in our sample. However, these mental health problems were not related with the control measure of quarantine, but the impacts on daily life. This finding is unusual but not unique (e.g., Wang et al., 2011, Li et al., 2020). During the H1N1 epidemic, we also found no immediate negative psychological effect of quarantine in college students (Wang et al., 2011). Instead, the dissatisfaction with control measures significantly predicted their negative psychological consequences. We endorse that, if quarantine is essential, the officials should take measures to ensure that this experience is acceptable and tolerable. Further studies should pay more attention to identify the potential psychological risk factors associated with the mental health problems under quarantine.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  44 in total

Review 1.  Psychological sequelae within different populations during the COVID-19 pandemic: a rapid review of extant evidence.

Authors:  Xin Jie Jordon Tng; Qian Hui Chew; Kang Sim
Journal:  Singapore Med J       Date:  2020-07-30       Impact factor: 3.331

2.  COVID-19 Pandemic and International Students' Mental Health in China: Age, Gender, Chronic Health Condition and Having Infected Relative as Risk Factors.

Authors:  Collins Opoku Antwi; Michelle Allyshia Belle; Seth Yeboah Ntim; Yuanchun Wu; Emmanuel Affum-Osei; Michael Osei Aboagye; Jun Ren
Journal:  Int J Environ Res Public Health       Date:  2022-06-28       Impact factor: 4.614

3.  Covid-19: high rates of severity and death in elderly and patients with chronic diseases reinforces the importance of regular physical activity.

Authors:  Guilherme F Speretta; Richard Diego Leite
Journal:  Sport Sci Health       Date:  2020-07-26

Review 4.  Vascular Events, Vascular Disease and Vascular Risk Factors-Strongly Intertwined with COVID-19.

Authors:  Adrian Scutelnic; Mirjam R Heldner
Journal:  Curr Treat Options Neurol       Date:  2020-10-08       Impact factor: 3.598

5.  Mental Burden of Hospital Workers During the COVID-19 Crisis: A Quanti-Qualitative Analysis.

Authors:  Amandine Luquiens; Jennifer Morales; Marion Bonneville; Hugo Potier; Pascal Perney; Gilles Faure; Astrid Canaguier
Journal:  Front Psychiatry       Date:  2021-04-23       Impact factor: 4.157

6.  Knowledge of COVID-19 and Its Influence on Mindfulness, Cognitive Emotion Regulation and Psychological Flexibility in the Indian Community.

Authors:  Neha Dubey; Priyanka Podder; Dinkar Pandey
Journal:  Front Psychol       Date:  2020-11-12

7.  Impact of Sleep Deprivation on Emotional Regulation and the Immune System of Healthcare Workers as a Risk Factor for COVID 19: Practical Recommendations From a Task Force of the Latin American Association of Sleep Psychology.

Authors:  Katie Moraes de Almondes; Hernán Andrés Marín Agudelo; Ulises Jiménez-Correa
Journal:  Front Psychol       Date:  2021-05-20

Review 8.  Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.

Authors:  S B Alam; S Willows; M Kulka; J K Sandhu
Journal:  Eur J Neurol       Date:  2020-08-14       Impact factor: 6.288

9.  COVID-19 pandemic and mental health consequences: Systematic review of the current evidence.

Authors:  Nina Vindegaard; Michael Eriksen Benros
Journal:  Brain Behav Immun       Date:  2020-05-30       Impact factor: 7.217

10.  The mental health impact of the covid-19 pandemic on healthcare workers, and interventions to help them: A rapid systematic review.

Authors:  Ashley Elizabeth Muller; Elisabet Vivianne Hafstad; Jan Peter William Himmels; Geir Smedslund; Signe Flottorp; Synne Øien Stensland; Stijn Stroobants; Stijn Van de Velde; Gunn Elisabeth Vist
Journal:  Psychiatry Res       Date:  2020-09-01       Impact factor: 11.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.